
Agenus Secures First $20 Million Contingent Payment from Zydus Life Sciences to Advance BOT+BAL Manufacturing Collaboration
Agenus Triggers First $20 Million Contingent Payment Under Zydus Collaboration Agenus, a leader in immuno-oncology innovation, announced that it has triggered the first $20 million contingent payment under its previously…











